FHIR IG analytics| Package | hl7.fhir.uv.xver-r5.r4.r4 |
| Resource Type | CodeSystem |
| Id | CodeSystem-substance-name-authority.json |
| FHIR Version | R4 |
| Source | http://hl7.org/fhir/uv/xver-r5.r4/0.0.1-snapshot-2/CodeSystem-substance-name-authority.html |
| URL | http://hl7.org/fhir/substance-name-authority |
| Version | 5.0.0 |
| Status | active |
| Date | 2021-01-05T09:01:24+10:00 |
| Name | SubstanceNameAuthority |
| Title | Substance Name Authority |
| Realm | uv |
| Authority | hl7 |
| Description | SubstanceNameAuthority |
| Content | complete |
| ValueSet | ||
| umcterminologies.org#current | substance-name-authority | Substance Name Authority Value Set |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-substance-name-authority-for-R4 | Cross-version VS for R5.SubstanceNameAuthority for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-substance-name-authority-for-R4 | Cross-version VS for R4B.SubstanceNameAuthority for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4#0.1.0 | R5-substance-name-authority-for-R4 | Cross-version ValueSet R5.SubstanceNameAuthority for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r3#0.1.0 | R5-substance-name-authority-for-R3 | Cross-version ValueSet R5.SubstanceNameAuthority for use in FHIR STU3 |
| hl7.fhir.uv.xver-r4b.r4#0.1.0 | R4B-substance-name-authority-for-R4 | Cross-version ValueSet R4B.SubstanceNameAuthority for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r3#0.1.0 | R4B-substance-name-authority-for-R3 | Cross-version ValueSet R4B.SubstanceNameAuthority for use in FHIR STU3 |
No resources found
Note: links and images are rebased to the (stated) source
This code system
http://hl7.org/fhir/substance-name-authority defines the following codes:
| Code | Display |
| BAN | BAN |
| COSING | COSING |
| Ph.Eur. | Ph.Eur. |
| FCC | FCC |
| INCI | INCI |
| INN | INN |
| JAN | JAN |
| JECFA | JECFA |
| MARTINDALE | MARTINDALE |
| USAN | USAN |
| USP | USP |
| PHF | PHF |
| HAB | HAB |
| PhF | PhF (Pharmacopée française) |
| IUIS | IUIS |
FHIR
FHIRsmith{
"resourceType": "CodeSystem",
"id": "substance-name-authority",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r5.r4"
},
{
"url": "version",
"valueString": "0.0.1-snapshot-2"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "brr"
}
],
"url": "http://hl7.org/fhir/substance-name-authority",
"version": "5.0.0",
"name": "SubstanceNameAuthority",
"title": "Substance Name Authority",
"status": "active",
"experimental": false,
"date": "2021-01-05T09:01:24+10:00",
"publisher": "Biomedical Research and Regulation",
"contact": [
{
"name": "Biomedical Research and Regulation",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description": "SubstanceNameAuthority",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"caseSensitive": true,
"valueSet": "http://hl7.org/fhir/ValueSet/substance-name-authority",
"content": "complete",
"concept": [
{
"code": "BAN",
"display": "BAN"
},
{
"code": "COSING",
"display": "COSING"
},
{
"code": "Ph.Eur.",
"display": "Ph.Eur."
},
{
"code": "FCC",
"display": "FCC"
},
{
"code": "INCI",
"display": "INCI"
},
{
"code": "INN",
"display": "INN"
},
{
"code": "JAN",
"display": "JAN"
},
{
"code": "JECFA",
"display": "JECFA"
},
{
"code": "MARTINDALE",
"display": "MARTINDALE"
},
{
"code": "USAN",
"display": "USAN"
},
{
"code": "USP",
"display": "USP"
},
{
"code": "PHF",
"display": "PHF"
},
{
"code": "HAB",
"display": "HAB"
},
{
"code": "PhF",
"display": "PhF (Pharmacopée française)"
},
{
"code": "IUIS",
"display": "IUIS"
}
]
}